Clinical efficacy and safety of Janus kinase inhibitors for COVID-19: A systematic review and meta-analysis of randomized controlled trials

OBJECTIVES: This systematic review and meta-analysis of randomized controlled trials (RCTs) aimed to investigate the clinical efficacy and safety of Janus kinase (JAK) inhibitors for COVID-19 patients. METHODS: PubMed, Embase, Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov we...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ching-Yi, Chen, Wang-Chun, Hsu, Chi-Kuei, Chao, Chien-Ming, Lai, Chih-Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324418/
https://www.ncbi.nlm.nih.gov/pubmed/34343937
http://dx.doi.org/10.1016/j.intimp.2021.108027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324418/
https://www.ncbi.nlm.nih.gov/pubmed/34343937
http://dx.doi.org/10.1016/j.intimp.2021.108027

Ejemplares similares